Advanced search
Publication Cover
International Journal of Hyperthermia Volume 37, 2020 - Issue 1
Submit an article Journal homepage
12,080
Views
208
CrossRef citations to date
0
Altmetric
Review

Heating technology for malignant tumors: a review

H. Petra Koka Department of Radiation Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8504-136XView further author information
ORCID Icon,
Erik N. K. Cressmanb Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Wim Ceelenc Department of GI Surgery, Ghent University Hospital, Ghent, BelgiumORCID Iconhttps://orcid.org/0000-0001-7692-4419View further author information
ORCID Icon,
Christopher L. Braced Department of Radiology and Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USAORCID Iconhttps://orcid.org/0000-0002-6777-6554View further author information
ORCID Icon,
Robert Ivkove Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA;f Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA;g Department of Mechanical Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, USA;h Department of Materials Science and Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, USAORCID Iconhttps://orcid.org/0000-0002-2930-5276View further author information
ORCID Icon,
Holger Grülli Department of Diagnostic and Interventional Radiology, Faculty of Medicine, University Hospital of Cologne, University of Cologne, Cologne, GermanyView further author information
,
Gail ter Haarj Department of Physics, The Institute of Cancer Research, London, UKView further author information
,
Peter Wustk Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, GermanyView further author information
&
Johannes Crezeea Department of Radiation Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-7474-0533View further author information
ORCID Icon show all
Pages 711-741 | Received 30 Dec 2019, Accepted 01 Jun 2020, Published online: 24 Jun 2020

References

  • Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. Am J Med Sci. 1893;105:487–511.
  • Rau B, Wust P, Tilly W, et al. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys. 2000;48:381–391.
  • Kroesen M, Mulder HT, Van Holthe JML, Aangeenbrug AA, et al. Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia. Radiother Oncol. 2019;140:150–158.
  • Bakker A, Van der Zee J, van Tienhoven G, et al. Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity: a systematic review. Int J Hyperthermia. 2019;36:1024–1039.
  • van Rhoon GC. Is CEM43 still a relevant thermal dose parameter for hyperthermia treatment monitoring? Int J Hyperthermia. 2016;32:50–62.
  • Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10:787–800.
  • Dewey WC, Hopwood LE, Sapareto SA, et al. Cellular responses to combinations of hyperthermia and radiation. Radiology. 1977;123:463–474.
  • Krawczyk PM, Eppink B, Essers J, et al. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci U S A. 2011;108:9851–9856.
  • Kampinga HH, Dikomey E. Hyperthermic radiosensitization: mode of action and clinical relevance. Int J Radiat Biol. 2001;77:399–408.
  • Jones EL, Prosnitz LR, Dewhirst MW, et al. Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer. Clin Cancer Res. 2004;10:4287–4293.
  • Vujaskovic Z, Song CW. Physiological mechanisms underlying heat-induced radiosensitization. Int J Hyperthermia. 2004;20:163–174.
  • Issels RD. Hyperthermia adds to chemotherapy. Eur J Cancer. 2008;44:2546–2554.
  • Bull JMC. A review of immune therapy in cancer and a question: can thermal therapy increase tumor response? Int J Hyperthermia. 2018;34:840–852.
  • Dewhirst MW, Vujaskovic Z, Jones E, et al. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia. 2005;21:779–790.
  • van den Tempel N, Laffeber C, Odijk H, et al. The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination. Oncotarget. 2017;8:44593–44604.
  • Prakash P, Diederich CJ. Considerations for theoretical modelling of thermal ablation with catheter-based ultrasonic sources: implications for treatment planning, monitoring and control. Int J Hyperthermia. 2012;28:69–86.
  • Calderwood SK, Theriault JR, Gong J. How is the immune response affected by hyperthermia and heat shock proteins? Int J Hyperthermia. 2005;21:713–716.
  • Skitzki JJ, Repasky EA, Evans SS. Hyperthermia as an immunotherapy strategy for cancer. Curr Opin Investig Drugs. 2009;10:550–558.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.
  • Dewhirst MW, Viglianti BL, Lora-Michiels M, et al. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia. 2003;19:267–294.
  • Cihoric N, Tsikkinis A, van Rhoon G, et al. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int J Hyperthermia. 2015;31:609–614.
  • Stauffer PR. Evolving technology for thermal therapy of cancer. Int J Hyperthermia. 2005;21:731–744.
  • Foster KR, Schwan HP. Dielectric properties of tissues and biological materials: a critical review. Crit Rev Biomed Eng. 1989;17:25–104.
  • Wust P, Seebass M, Nadobny J, et al. Electromagnetic deep heating technology. In: Seegenschmiedt MH, Fessenden P, Vernon CC, editors. Thermoradiotherapy and thermochemotherapy. Volume 1, Biology, physiology and physics. Berlin: Springer Verlag; 1995. p. 219–251.
  • Griffiths DJ. Introduction to electrodynamics. 2nd ed. Englewood Cliffs (NJ): Prentice Hall International; 1989.
  • Gabriel S, Lau RW, Gabriel C. The dielectric properties of biological tissues: II. Measurements in the frequency range 10 Hz to 20 GHz. Phys Med Biol. 1996;41:2251–2269.
  • Kok HP, Navarro F, Strigari L, et al. Locoregional hyperthermia of deep-seated tumours applied with capacitive and radiative systems: a simulation study. Int J Hyperthermia. 2018;34:714–730.
  • Kok HP, Crezee J. A comparison of the heating characteristics of capacitive and radiative superficial hyperthermia. Int J Hyperthermia. 2017;33:378–386.
  • Hiraoka M, Jo S, Akuta K, et al. Radiofrequency capacitive hyperthermia for deep-seated tumors. I. Studies on thermometry. Cancer. 1987;60:121–127.
  • Lee SY, Kim JH, Han YH, et al. The effect of modulated electro-hyperthermia on temperature and blood flow in human cervical carcinoma. Int J Hyperthermia. 2018;34:953–960.
  • Ohguri T, Harima Y, Imada H, et al. Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial. Int J Hyperthermia. 2018;34:461–468.
  • Ho JC, Nguyen L, Law JJ, et al. Non-invasive radiofrequency field treatment to produce hepatic hyperthermia: efficacy and safety in swine. IEEE J Transl Eng Health Med. 2017;5:1500109.
  • Vrba J, Franconi C, Lapes M. Theoretical limits for the penetration depth of intracavitary applicators. Int J Hyperthermia. 1996;12:737–742.
  • Kok HP, Korshuize - van Straten L, Bakker A, et al. Online adaptive hyperthermia treatment planning during locoregional heating to suppress treatment-limiting hot spots. Int J Radiat Oncol Biol Phys. 2017;99:1039–1047.
  • Lassche G, Crezee J, Van Herpen CML. Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies. Crit Rev Oncol Hematol. 2019;139:67–74.
  • Missios S, Bekelis K, Barnett GH. Renaissance of laser interstitial thermal ablation. Neurosurg Focus. 2015;38:E13.
  • Diederich CJ, Hynynen K. Ultrasound technology for hyperthermia. Ultrasound Med Biol. 1999;25:871–887.
  • Zhu L, Altman MB, Laszlo A, et al. Ultrasound hyperthermia technology for radiosensitization. Ultrasound Med Biol. 2019;45:1025–1043.
  • Sebeke L, Deenen DA, Maljaars E, et al. Model predictive control for MR-HIFU-mediated, uniform hyperthermia. Int J Hyperthermia. 2019;36:1040–1050.
  • Salomir R, Vimeux FC, de Zwart JA, et al. Hyperthermia by MR-guided focused ultrasound: accurate temperature control based on fast MRI and a physical model of local energy deposition and heat conduction. Magn Reson Med. 2000;43:342–347.
  • Quesson B, Vimeux F, Salomir R, et al. Automatic control of hyperthermic therapy based on real-time Fourier analysis of MR temperature maps. Magn Reson Med. 2002;47:1065–1072.
  • Tillander M, Hokland S, Koskela J, et al. High intensity focused ultrasound induced in vivo large volume hyperthermia under 3D MRI temperature control. Med Phys. 2016;43:1539–1549.
  • Coussios CC, Farny CH, Haar GT, et al. Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focused ultrasound (HIFU). Int J Hyperthermia. 2007;23:105–120.
  • Ebbini ES, ter Haar G. Ultrasound-guided therapeutic focused ultrasound: current status and future directions. Int J Hyperthermia. 2015;31:77–89.
  • Ter Haar G. HIFU tissue ablation: concept and devices. Adv Exp Med Biol. 2016;880:3–20.
  • Bing C, Ladouceur-Wodzak M, Wanner CR, et al. Trans-cranial opening of the blood-brain barrier in targeted regions using a stereotaxic brain atlas and focused ultrasound energy. J Ther Ultrasound. 2014;2:13.
  • Kwan JJ, Myers R, Coviello CM, Graham SM, et al. Ultrasound-propelled nanocups for drug delivery. Small. 2015;11:5305–5314.
  • Treat LH, McDannold N, Zhang Y, et al. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol. 2012;38:1716–1725.
  • Rahim AA, Taylor SL, Bush NL, et al. Spatial and acoustic pressure dependence of microbubble-mediated gene delivery targeted using focused ultrasound. J Gene Med. 2006;8:1347–1357.
  • Kennedy JE, Wu F, ter Haar GR, et al. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics. 2004;42:931–935.
  • Rodrigues DB, Stauffer PR, Vrba D, et al. Focused ultrasound for treatment of bone tumours. Int J Hyperthermia. 2015;31:260–271.
  • ten Eikelder HM, Bosnacki D, Elevelt A, et al. Modelling the temperature evolution of bone under high intensity focused ultrasound. Phys Med Biol. 2016;61:1810–1828.
  • Helderman R, Loke DR, Kok HP, et al. Variation in clinical application of hyperthermic intraperitoneal chemotherapy: a review. Cancers (Basel). 2019;11:78.
  • de Bree E, van Ruth S, Baas P, et al. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma. Chest. 2002;121:480–487.
  • Sousa A, Pineiro I, Rodriguez S, et al. Recirculant hyperthermic IntraVEsical chemotherapy (HIVEC) in intermediate-high-risk non-muscle-invasive bladder cancer. Int J Hyperthermia. 2016;32:374–380.
  • Westermark F. Uber die behandlung des ulzerierenden cervixkarzinoms mittels konstanter warme. Zentralbl Gynakol. 1898;22:1335–1339.
  • van Wieringen N, van Dijk JD, Nieuwenhuys GJ, et al. Power absorption and temperature control of multi-filament palladium-nickel thermoseeds for interstitial hyperthermia. Phys Med Biol. 1996;41:2367–2380.
  • Gilchrist RK, Medal R, Shorey WD, et al. Selective inductive heating of lymph nodes. Ann Surg. 1957;146:596–606.
  • Wust P, Gneveckow U, Johannsen M, et al. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int J Hyperthermia. 2006;22:673–685.
  • Lanier OL, Korotych OI, Monsalve AG, et al. Evaluation of magnetic nanoparticles for magnetic fluid hyperthermia. Int J Hyperthermia. 2019;36:687–701.
  • Jordan A, Wust P, Fahling H, et al. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia. 1993;9:51–68.
  • Eggeman AS, Majetich SA, Farrell D, et al. Size and concentration effects on high frequency hysteresis of iron oxide nanoparticles. IEEE Trans Magn. 2007;43:2451–2453.
  • Dennis CL, Ivkov R. Physics of heat generation using magnetic nanoparticles for hyperthermia. Int J Hyperthermia. 2013;29:715–729.
  • Dennis CL, Krycka KL, Borchers JA, et al. Internal magnetic structure of nanoparticles dominates time-dependent relaxation processes in a magnetic field. Adv Funct Mater. 2015;25:4300–4311.
  • Mahmoudi K, Bouras A, Bozec D, et al. Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans. Int J Hyperthermia. 2018;34:1316–1328.
  • Sharma A, Cornejo C, Mihalic J, et al. Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles. Sci Rep. 2018;8:4916.
  • Gruttner C, Muller K, Teller J, et al. Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy. J Magn Magn Mater. 2007;311:181–186.
  • Dennis CL, Jackson AJ, Borchers JA, et al. Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia. Nanotechnology. 2009;20:395103.
  • Gruttner C, Muller K, Teller J, et al. Synthesis and functionalisation of magnetic nanoparticles for hyperthermia applications. Int J Hyperthermia. 2013;29:777–789.
  • Lyon PC, Gray MD, Mannaris C, et al. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial. Lancet Oncol. 2018;19:1027–1039.
  • Zhou J, Li L, Li X, et al. Efficacy analysis of a novel thermochemotherapy scheme with pirarubicin for intermediate- and high-risk nonmuscle-invasive bladder cancer: a singleinstitution nonrandomized concurrent controlled trial. Int J Hyperthermia. 2019;36:867–875.
  • Colombo R, Salonia A, Leib Z, et al. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU.Int. 2011;107:912–918.
  • Arends TJH, Nativ O, Maffezzini M, et al. Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus Bacillus Calmette-Guerin for adjuvant treatment of patients with intermediate- and high-risk non-muscle-invasive bladder cancer. Eur Urol. 2016;69:1046–1052.
  • Tan WS, Panchal A, Buckley L, et al. Radiofrequency-induced thermo-chemotherapy effect versus a second course of Bacillus Calmette-Guérin or institutional standard in patients with recurrence of non-muscle-invasive bladder cancer following induction or maintenance Bacillus Calmette-Guérin Therapy (HYMN): a phase III, open-label, randomised controlled trial. Eur Urol. 2019;75:63–71.
  • Ohno S, Tomoda M, Tomisaki S, et al. Improved surgical results after combining preoperative hyperthermia with chemotherapy and radiotherapy for patients with carcinoma of the rectum. Dis Colon Rectum. 1997;40:401–406.
  • Takahashi M, Fujimoto S, Kobayashi K, et al. Clinical outcome of intraoperative pelvic hyperthermochemotherapy for patients with Dukes' C rectal cancer. Int J Hyperthermia. 1994;10:749–754.
  • Huilgol NG, Gupta S, Dixit R. Chemoradiation with hyperthermia in the treatment of head and neck cancer. Int J Hyperthermia. 2010;26:21–25.
  • Ohguri T, Imada H, Narisada H, et al. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results. Int J Hyperthermia. 2009;25:160–167.
  • Moon SD, Ohguri T, Imada H, et al. Definitive radiotherapy plus regional hyperthermia with or without chemotherapy for superior sulcus tumors: a 20-year, single center experience. Lung Cancer. 2011;71:338–343.
  • Kodama K, Doi O, Higashiyama M, et al. Long-term results of postoperative intrathoracic chemo-thermotherapy for lung cancer with pleural dissemination. Cancer. 1993;72:426–431.
  • Ohguri T, Imada H, Nomoto S, et al. Initial experience of bladder preservation therapy using chemoradiotherapy with regional hyperthermia for muscle-invasive bladder cancer. Jpn J Hyperthermic Oncol. 2005;21:151–157.
  • Nagata Y, Hiraoka M, Nishimura Y, et al. Clinical results of radiofrequency hyperthermia for malignant liver tumors. Int J Radiat Oncol Biol Phys. 1997;38:359–365.
  • Murata T, Akagi K, Imamura M, et al. Studies on hyperthermia combined with arterial therapeutic blockade for treatment of tumors: (Part III) effectiveness of hyperthermia combined with arterial chemoembolization using degradable starch microspheres on advanced liver cancer. Oncol Rep. 1998;5:709–712.
  • Minnaar CA, Kotzen JA, Ayeni OA, et al. The effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: early results from a phase III randomised controlled trial. PLoS One. 2019;14:e0217894
  • Harima Y, Ohguri T, Imada H, et al. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer. Int J Hyperthermia. 2016;32:801–808.
  • Ohguri T, Imada H, Yahara K, et al. Concurrent chemoradiotherapy with gemcitabine plus regional hyperthermia for locally advanced pancreatic carcinoma: initial experience. Radiat Med. 2008;26:587–596.
  • Saeki H, Kawaguchi H, Kitamura K, et al. Recent advances in preoperative hyperthermochemoradiotherapy for patients with esophageal cancer. J Surg Oncol. 1998;69:224–229.
  • Sugimach K, Kuwano H, Ide H, et al. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int.J.Hyperthermia. 1994;10:485–493.
  • Issels RD, Lindner Lh, Verweij J, Wessalowski R, et al.; European Organization for the Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group and the European Society for Hyperthermic Oncology. Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 Randomized Clinical Trial. JAMA Oncol. 2018;4:483–492.
  • Wessalowski R, Schneider DT, Mils O, et al.; MAKEI study group. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study. Lancet Oncol. 2013;14:843–852.
  • Wessalowski R, Schneider DT, Mils O, et al. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors. Klin Padiatr. 2003;215:303–309.
  • Seifert G, Budach V, Keilholz U, et al. Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives. Radiat Oncol. 2016;11:65.
  • Tschoep-Lechner KE, Milani V, Berger F, et al. Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer. Int J Hyperthermia. 2013;29:8–16.
  • Beck M, Ghadjar P, Weihrauch M, et al. Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis. Radiat Oncol. 2015;10:157.
  • Maluta S, Schaffer M, Pioli F, et al. Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial. Strahlenther Onkol. 2011;187:619–625.
  • Geijsen ED, De Reijke TM, Koning CCE, et al. Combining mitomycin C and regional 70 MHz hyperthermia in patients with nonmuscle invasive bladder cancer: a pilot study. J Urol. 2015;194:1202–1208.
  • Inman BA, Stauffer PR, Craciunescu OA, et al. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia. 2014;30:171–175.
  • Westermann A, Mella O, van der Zee J, et al. Long-term survival data of triple modality treatment of stage IIB-III-IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia – an update. Int J Hyperthermia. 2012;28:549–553.
  • Hulshof MC, Van Haaren PM, van Lanschot JJ, et al. Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer. Int J Hyperthermia. 2009;25:79–85.
  • Cho C, Wust P, Hildebrandt B, et al. Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: evaluation of two annular-phased-array applicators. Int J Hyperthermia. 2008;24:399–408.
  • Petrovich Z, Langholz B, Kapp DS, et al. Deep regional hyperthermia of the liver. A clinical study of 49 patients. Am J Clin Oncol. 1989;12:378–383.
  • van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med. 2018;378:230–240.
  • Bonnot PE, Piessen G, Kepenekian V, et al.; FREGAT and BIG-RENAPE Networks. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37:2028–2040.
  • Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–3743.
  • Quenet F, Elias D, Roca L, et al.; UNICANCER-GI Group and the French BIG-Renape Group. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018;36:LBA3503.
  • Koops HS, Vaglini M, Suciu S, et al. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593. J Clin Oncol. 1998;16:2906–2912.
  • Eggermont AM, de Wilt JH, ten Hagen TL. Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol. 2003;4:429–437.
  • Van Vulpen M, Raaymakers BW, Lagendijk JJW, et al. Three-dimensional controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma-a feasibility study. Int J Radiat Oncol Biol Phys. 2002;53:116–126.
  • Kukielka AM, Hetnal M, Bereza K. Evaluation of tolerance and toxicity of high-dose-rate brachytherapy boost combined with interstitial hyperthermia for prostate cancer. Int J Hyperthermia. 2016;32:324–330.
  • Sneed PK, Stauffer PR, McDermott MW, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1998;40:287–295.
  • Engin K, Tupchong L, Waterman FM, et al. Thermoradiotherapy with combined interstitial and external hyperthermia in advanced tumours in the head and neck with depth > or = 3 cm. Int J Hyperthermia. 1993;9:645–654.
  • Maier-Hauff K, Ulrich F, Nestler D, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 2011;103:317–324.
  • Johannsen M, Thiesen B, Wust P, et al. Magnetic nanoparticle hyperthermia for prostate cancer. Int J Hyperthermia. 2010;26:790–795.
  • Ren RL, Chou CK, Vora N, et al. A pilot study of intracavitary hyperthermia combined with radiation in the treatment of oesophageal carcinoma. Int J Hyperthermia. 1998;14:245–254.
  • You QS, Wang RZ, Suen GQ, et al. Combination preoperative radiation and endocavitary hyperthermia for rectal cancer: long-term results of 44 patients. Int J Hyperthermia. 1993;9:19–24.
  • Huilgol NG, Gupta S, Sridhar CR. Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Can Res Ther. 2010;6:492–496.
  • Abe M, Hiraoka M, Takahashi M, et al. Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer. 1986;58:1589–1595.
  • Matsuda T, Tanaka Y, Takeshita N, et al. Clinical significance of the combined use of radiation therapy and hyperthermia]. Gan to Kagaku Ryoho. 1987;14:1508–1514.
  • van Stam G, Kok HP, Hulshof M, et al. A flexible 70 MHz phase-controlled double waveguide system for hyperthermia treatment of superficial tumours with deep infiltration . Int J Hyperthermia. 2017;33:796–809.
  • Crezee J, Van Tienhoven G, Kolff MW, et al. Development of a 70 MHz unit for hyperthermia treatment of deep-seated breast tumors. Int J Microw Wireless Technol. 2017;9:1317–1324.
  • Verduijn GM, de Wee EM, Rijnen Z, et al. Deep hyperthermia with the HYPERcollar system combined with irradiation for advanced head and neck carcinoma – a feasibility study. Int J Hyperthermia. 2018;34:994–1001.
  • Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int.J.Radiat.Oncol.Biol.Phys. 1996;35:731–744.
  • Overgaard J, González González D, Hulshof M, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet. 1995;345:540–543.
  • Overgaard J, Gonzalez DG, Hulshof M, et al. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. International Journal of Hyperthermia. 1996;12:3–20.
  • Arcangeli G, Benassi M, Cividalli A, Radiotherapy and hyperthermia, et al. Analysis of clinical results and identification of prognostic variables. Cancer. 1987;60:950–956.
  • Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys. 1994;28:163–169.
  • Ohguri T, Imada H, Yahara K, et al. Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes. Int J Radiat Oncol Biol Phys. 2009;73:128–135.
  • Ohguri T, Imada H, Yahara K, et al. Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients. Lung Cancer. 2012;77:140–145.
  • Ohguri T, Yahara K, Moon SD, et al. Deep regional hyperthermia for the whole thoracic region using 8 MHz radiofrequency-capacitive heating device: relationship between the radiofrequency-output power and the intra-oesophageal temperature and predictive factors for a good heating in 59 patients. Int J Hyperthermia. 2011;27:20–26.
  • Tomura K, Ohguri T, Mulder HT, et al. The usefulness of mobile insulator sheets for the optimization of deep heating area for regional hyperthermia using a capacitively-coupled heating method: phantom, simulation and clinical prospective studies. Int J Hyperthermia. 2018;34:1092–1103.
  • Yahara K, Ohguri T, Yamaguchi S, et al. Definitive radiotherapy plus regional hyperthermia for high-risk and very high-risk prostate carcinoma: thermal parameters correlated with biochemical relapse-free survival. Int J Hyperthermia. 2015;31:600–608.
  • Masunaga SI, Hiraoka M, Akuta K, et al. Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer. Int J Hyperthermia. 1994;10:31–40.
  • Ohguri T, Imada H, Kato F, et al. Radiotherapy with 8 MHz radiofrequency-capacitive regional hyperthermia for pain relief of unresectable and recurrent colorectal cancer. Int J Hyperthermia. 2006;22:1–14.
  • Ohguri T, Imada H, Yahara K, et al. Effect of 8-MHz radiofrequency-capacitive regional hyperthermia with strong superficial cooling for unresectable or recurrent colorectal cancer. Int J Hyperthermia. 2004;20:465–475.
  • Chi MS, Yang KL, Chang YC, et al. Comparing the effectiveness of combined external beam radiation and hyperthermia versus external beam radiation alone in treating patients with painful bony metastases: a phase 3 prospective, randomized, controlled trial. Int J Radiat Oncol Biol Phys. 2018;100:78–87.
  • Harima Y, Nagata K, Harima K, et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia. 2001;17:97–105.
  • Yamada S, Takai Y, Nemoto K, et al. Intraoperative radiation therapy combined with hyperthermia against pancreatic carcinoma. Tohoku J Exp Med. 1992;166:395–401.
  • Yamaguchi S, Ohguri T, Imada H, et al. Multimodal approaches including three-dimensional conformal re-irradiation for recurrent or persistent esophageal cancer: preliminary results. J Radiat Res. 2011;52:812–820.
  • Van der Zee J, González González D, Van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 2000;355:1119–1125.
  • Maluta S, Dall'Oglio S, Romano M, et al. Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study. Int J Hyperthermia. 2007;23:451–456.
  • Tilly W, Gellermann J, Graf R, et al. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol. 2005;181:35–41.
  • Lubner MG, Brace CL, Hinshaw JL, et al. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21:S192–S203.
  • Rosenthal DI, Hornicek FJ, Torriani M, et al. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology. 2003;229:171–175.
  • Phoa KN, van Vilsteren FG, Weusten BL, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311:1209–1217.
  • Tan W, Deng Q, Lin S, et al. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36:264–272.
  • Luo W, Zhang Y, He G, et al. Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis. World J Surg Onc. 2017;15:126.
  • Bi N, Shedden K, Zheng X, et al. Comparison of the effectiveness of radiofrequency ablation with stereotactic body radiation therapy in inoperable stage I non-small cell lung cancer: a systemic review and pooled analysis. Int J Radiat Oncol Biol Phys. 2016;95:1378–1390.
  • Tsakok MT, Jones D, MacNeill A, et al. Is microwave ablation more effective than radiofrequency ablation in achieving local control for primary pulmonary malignancy? Interact Cardiovasc Thorac Surg. 2019.
  • Sidoff L, Dupuy DE. Clinical experiences with microwave thermal ablation of lung malignancies. Int J Hyperthermia. 2017;33:25–33.
  • Hamou AB, Ghanassia E, Espiard SA, et al. Safety and efficacy of thermal ablation (radiofrequency and laser): should we treat all types of thyroid nodules? Int J Hyperthermia. 2019;36:666–676.
  • Wang L, Xu D, Yang Y, et al. Safety and efficacy of ultrasound-guided percutaneous thermal ablation in treating low-risk papillary thyroid microcarcinoma: a pilot and feasibility study. J Cancer Res Ther. 2019;15:1522–1529.
  • Cho SJ, Baek JH, Chung SR, et al. Thermal ablation for small papillary thyroid cancer: a systematic review. Thyroid. 2019;29:1774–1783.
  • Papini E, Pacella CM, Solbiati LA, et al. G, Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperthermia. 2019;36:376–382.
  • Filippiadis D, Mauri G, Marra P, et al. F, Percutaneous ablation techniques for renal cell carcinoma: current status and future trends. Int J Hyperthermia. 2019;36:21–30.
  • Higgins LJ, Hong K. Renal ablation techniques: state of the art. AJR Am J Roentgenol. 2015;205:735–741.
  • Garcia-Tejedor A, Guma A, Soler T, et al. Radiofrequency ablation followed by surgical excision versus lumpectomy for early stage breast cancer: a randomized phase II clinical trial. Radiology. 2018;289:317–324.
  • Pouw RE, Klaver E, Phoa KN, et al. Radiofrequency ablation for low-grade dysplasia in Barrett’s esophagus: long-term outcome of a randomized trial. Gastrointest Endosc. 2020.
  • Saccomandi P, Lapergola A, Longo F, et al. Thermal ablation of pancreatic cancer: a systematic literature review of clinical practice and pre-clinical studies. Int J Hyperthermia. 2018;35:398–418.
  • Vietti Violi N, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3:317–325.
  • Macchi M, Belfiore MP, Floridi C, et al. Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial. Med Oncol. 2017;34:96.
  • Vogl TJ, Eckert R, Naguib NN, et al. Thermal ablation of colorectal lung metastases: retrospective comparison among laser-induced thermotherapy, radiofrequency ablation, and microwave ablation. AJR Am J Roentgenol. 2016;207:1340–1349.
  • Narsule CK, Sridhar P, Nair D, et al. Percutaneous thermal ablation for stage IA non-small cell lung cancer: long-term follow-up. J Thorac Dis. 2017;9:4039–4045.
  • Wang L, Ke Q, Lin N, et al. The efficacy of transarterial chemoembolization combined with microwave ablation for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36:1288–1296.
  • Barnett GH, Voigt JD, Alhuwalia MS. A systematic review and meta-analysis of studies examining the use of brain laser interstitial thermal therapy versus craniotomy for the treatment of high-grade tumors in or near areas of eloquence: an examination of the extent of resection and major complication rates associated with each type of surgery. Stereotact Funct Neurosurg. 2016;94:164–173.
  • Ahluwalia M, Barnett GH, Deng D, et al. Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis. J Neurosurg. 2019;130:804–811.
  • Kramer MW, Wolters M, Cash H, et al. Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014. World J Urol. 2015;33:571–579.
  • Woods E. Laser ablation of the prostate: a safe effective treatment of obstructive benign prostatic disease. Can Urol Assoc J. 2010;4:344–346.
  • Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol. 2010;58:349–355.
  • Schlottmann F, Patti MG. Current concepts in treatment of Barrett's esophagus with and without dysplasia. J Gastrointest Surg. 2017;21:1354–1360.
  • Tucker RD, Platz CE, Huidobro C, et al. Interstitial thermal therapy in patients with localized prostate cancer: histologic analysis. Urology. 2002;60:166–169.
  • Sherar MD, Trachtenberg J, Davidson SR, et al. Interstitial microwave thermal therapy for prostate cancer. J Endourol. 2003;17:617–625.
  • Chopra R, Colquhoun A, Burtnyk M, et al. L, MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. Radiology. 2012;265:303–313.
  • Elias WJ, Lipsman N, Ondo WG, et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2016;375:730–739.
  • Ikink ME, Voogt MJ, Verkooijen HM, et al. Mid-term clinical efficacy of a volumetric magnetic resonance-guided high-intensity focused ultrasound technique for treatment of symptomatic uterine fibroids. Eur Radiol. 2013;23:3054–3061.
  • Łoziński T, Filipowska J, Gurynowicz G, et al. The effect of high-intensity focused ultrasound guided by magnetic resonance therapy on obstetrical outcomes in patients with uterine fibroids - experiences from the main Polish center and a review of current data. Int J Hyperthermia. 2019;36:582–590.
  • Pron G. Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) treatment of symptomatic uterine fibroids: an evidence-based analysis. Ont Health Technol Assess Ser. 2015;15:1–86.
  • Hurwitz MD, Ghanouni P, Kanaev SV, et al. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. J Natl Cancer Inst. 2014;106:dju082.
  • Golan R, Bernstein AN, McClure TD, et al. Partial gland treatment of prostate cancer using high-intensity focused ultrasound in the primary and salvage settings: a systematic review. J Urol. 2017;198:1000–1009.
  • Guillaumier S, Peters M, Arya M, et al. A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer. Eur Urol. 2018;74:422–429.
  • Rischmann P, Gelet A, Riche B, et al. Focal high intensity focused ultrasound of unilateral localized prostate cancer: a prospective multicentric hemiablation study of 111 patients. Eur Urol. 2017;71:267–273.
  • Ghai S, Perlis N, Lindner U, et al. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer – phase 1 trial. Eur Radiol. 2018;28:4281–4287.
  • Tay KJ, Cheng CWS, Lau WKO, et al. Focal therapy for prostate cancer with in-bore MR-guided focused ultrasound: two-year follow-up of a phase i trial-complications and functional outcomes. Radiology. 2017;285:620–628.
  • Crouzet S, Blana A, Murat FJ, et al. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: multi-institutional analysis of 418 patients. BJU Int. 2017;119:896–904.
  • Cordeiro ER, Cathelineau X, Thuroff S, et al. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer. BJU Int. 2012;110:1228–1242.
  • Dababou S, Marrocchio C, Rosenberg J, et al. A meta-analysis of palliative treatment of pancreatic cancer with high intensity focused ultrasound. J Ther Ultrasound. 2017;5:9.
  • Peek MCL, Ahmed M, Scudder J, et al.; on behalf of the HIFU-F Collaborators. High-intensity focused ultrasound in the treatment of breast fibroadenomata (HIFU-F trial). Int J Hyperthermia. 2018;34:1002–1009.
  • Yu W, Tang L, Lin F, et al. Significance of HIFU in local unresectable recurrence of soft tissue sarcoma, a single-center, respective, case series in China. Surg Oncol. 2019;30:117–121.
  • Sharma KV, Yarmolenko PS, Eranki A, et al. Magnetic resonance imaging-guided high-intensity focused ultrasound applications in pediatrics: early experience at Children’s National Medical Center. Top Magn Reson Imaging. 2018;27:45–51.
  • Illing RO, Kennedy JE, Wu F, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer. 2005;93:890–895.
  • Melodelima D, Prat F, Fritsch J, et al. Treatment of esophageal tumors using high intensity intraluminal ultrasound: first clinical results. J Transl Med. 2008;6:28.
  • Maloney E, Hwang JH. Emerging HIFU applications in cancer therapy. Int J Hyperthermia. 2015;31:302–309.
  • Zhao WP, Zhang J, Han ZY, et al. A clinical investigation treating different types of fibroids identified by MRI-T2WI imaging with ultrasound guided high intensity focused ultrasound. Sci Rep. 2017;7:10812.
  • Scheffer HJ, Nielsen K, de Jong MC, et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol. 2014;25:997–1011. Quiz 1011.
  • Scheffer HJ, Vroomen L, de Jong MC, et al. Ablation of locally advanced pancreatic cancer with percutaneous irreversible electroporation: results of the phase I/II PANFIRE study. Radiology. 2017;282:585–597.
  • Vogel JA, Rombouts SJ, de Rooij T, et al. Induction chemotherapy followed by resection or irreversible electroporation in locally advanced pancreatic cancer (IMPALA): a prospective cohort study. Ann Surg Oncol. 2017;24:2734–2743.
  • Kourounis G, Tabet PP, Moris D, et al. Irreversible electroporation (Nanoknife (R) treatment) in the field of hepatobiliary surgery: current status and future perspectives. J Buon. 2017;22:141–149.
  • Guenther E, Klein N, Zapf S, et al. Prostate cancer treatment with irreversible electroporation (IRE): safety, efficacy and clinical experience in 471 treatments. Plos One. 2019;14:e0215093.
  • Ricke J, Jurgens JHW, Deschamps F, et al. Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial. Cardiovasc Intervent Radiol. 2015;38:401–408.
  • Soria F, Milla P, Fiorito C, et al. Efficacy and safety of a new device for intravesical thermochemotherapy in non-grade 3 BCG recurrent NMIBC: a phase I-II study. World J Urol. 2016;34:189–195.
  • Ba M, Cui S, Wang B, et al. Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection. Oncol Rep. 2017;37:2761–2770.
  • Okamura T, Ueda K, Hashimoto Y, et al. Immunohistochemical evaluation of p53 and retinoblastoma proteins in relation to hyperthermia treatment: results in human urothelial carcinomas. Int J Hyperthermia. 1996;12:813–824.
  • Merten R, Ott O, Haderlein M, et al. Long-term experience of chemoradiotherapy combined with deep regional hyperthermia for organ preservation in high-risk bladder cancer (Ta, Tis, T1, T2). Oncologist. 2019;24:e1341–e1350.
  • Mohammadi AM, Schroeder JL. Laser interstitial thermal therapy in treatment of brain tumors-the NeuroBlate System. Expert Rev Med Devices. 2014;11:109–119.
  • Sneed PK, Gutin PH, Stauffer PR, et al. Thermoradiotherapy of recurrent malignant brain tumors. Int J Radiat Oncol Biol Phys. 1992;23:853–861.
  • Hulshof MC, Raaymakers BW, Lagendijk JJ, et al. A feasibility study of interstitial hyperthermia plus external beam radiotherapy in glioblastoma multiforme using the Multi ELectrode Current Source (MECS) system. Int J Hyperthermia. 2004;20:451–463.
  • Rodriguez A, Tatter SB. Laser ablation of recurrent malignant gliomas: current status and future perspective. Neurosurgery. 2016;79:S35–S39.
  • He M, Jacobson H, Zhang C, et al. A retrospective study of ultrasound-guided high intensity focussed ultrasound ablation for multiple uterine fibroids in South Africa. Int J Hyperthermia. 2018;34:1304–1310.
  • Franckena M, Stalpers LJ, Koper PC, et al. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys. 2008;70:1176–1182.
  • Notter M, Piazena H, Vaupel P. Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermography-controlled, contact-free water-filtered infra-red-A hyperthermia: a retrospective study of 73 patients. Int J Hyperthermia. 2017;33:227–236.
  • van der Zee J, van der Holt B, Rietveld PJ, et al. Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation. Br J Cancer. 1999;79:483–490.
  • Samulski TV, Grant WJ, Oleson JR, et al. Clinical experience with a multi-element ultrasonic hyperthermia system: analysis of treatment temperatures. Int J Hyperthermia. 1990;6:909–922.
  • Zagar TM, Oleson JR, Vujaskovic Z, et al. Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: a review of the randomised data. Int J Hyperthermia. 2010;26:612–617.
  • Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005;23:3079–3085.
  • Shin BJ, Chick JF, Stavropoulos SW. Contemporary status of percutaneous ablation for the small renal mass. Curr Urol Rep. 2016;17:23.
  • Amabile C, Ahmed M, Solbiati L, et al. Microwave ablation of primary and secondary liver tumours: ex vivo, in vivo, and clinical characterisation. Int J Hyperthermia. 2017;33:34–42.
  • Filippiadis DK, Spiliopoulos S, Konstantos C, et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms. Int J Hyperthermia. 2018;34:863–869.
  • Imajo K, Tomeno W, Kanezaki M, et al. New microwave ablation system for unresectable liver tumors that forms large, spherical ablation zones. J Gastroenterol Hepatol. 2018;33:2007–2014.
  • Loriaud A, Denys A, Seror O, et al. A, Hepatocellular carcinoma abutting large vessels: comparison of four percutaneous ablation systems. Int J Hyperthermia. 2018;34:1171–1178.
  • Smolock AR, Cristescu MM, Potretzke TA, et al. Microwave ablation for the treatment of hepatic adenomas. J Vasc Interv Radiol. 2016;27:244–249.
  • Vogl TJ, Roman A, Nour-Eldin NA, et al. A comparison between 915 MHz and 2450 MHz microwave ablation systems for the treatment of small diameter lung metastases. Diagn Interv Radiol. 2018;24:31–37.
  • Ierardi AM, Coppola A, Lucchina N, et al. Treatment of lung tumours with high-energy microwave ablation: a single-centre experience. Med Oncol. 2017;34:5.
  • Klaver CEL, Stam R, Sloothaak DAM, et al. Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives. Oncotarget. 2017;8:51200–51209.
  • Cowan RA, O'Cearbhaill RE, Zivanovic O, et al. Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer. Int J Hyperthermia. 2017;33:548–553.
  • Pinto A, Eveno C, Pocard M. Update on clinical trials in colorectal cancer peritoneal metastasis. Int J Hyperthermia. 2017;33:543–547.
  • Goere D, Passot G, Gelli M, et al. Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI). Int J Hyperthermia. 2017;33:520–527.
  • Rovers KP, de Bree E, Yonemura Y, et al. Treatment of peritoneal metastases from small bowel adenocarcinoma. Int J Hyperthermia. 2017;33:571–578.
  • Ryan TP, Brace CL. Interstitial microwave treatment for cancer: historical basis and current techniques in antenna design and performance. Int J Hyperthermia. 2017;33:3–14.
  • Salgaonkar VA, Diederich CJ. Catheter-based ultrasound technology for image-guided thermal therapy: current technology and applications. Int J Hyperthermia. 2015;31:203–215.
  • Dobsicek Trefna H, Schmidt M, van Rhoon GC, et al. Quality assurance guidelines for interstitial hyperthermia. Int J Hyperthermia. 2019;36:277–294.
  • Stauffer PR, Diederich CJ, Seegenschmiedt MH. Interstitial heating technologies. In: Seegenschmiedt MH, Fessenden P, Vernon CC, editors. Thermoradiotherapy and thermochemotherapy. Volume 1, Biology, physiology and physics. Berlin: Springer Verlag; 1995. p. 279–320.
  • Fallahi H, Prakash P. Antenna designs for microwave tissue ablation. Crit Rev Biomed Eng. 2018;46:495–521.
  • Schreier K, Budihna M, Lesnicar H, et al. Preliminary studies of interstitial hyperthermia using hot water. Int J Hyperthermia. 1990;6:431–444.
  • Deford JA, Babbs CF, Patel UH, et al. Effective estimation and computer control of minimum tumour temperature during conductive interstitial hyperthermia. Int J Hyperthermia. 1991;7:441–453.
  • Stauffer PR, Cetas TC, Fletcher AM, et al. Observations on the use of ferromagnetic implants for inducing hyperthermia. IEEE Trans Biomed Eng. 1984;31:76–90.
  • Steger AC, Lees WR, Walmsley K, et al. Interstitial laser hyperthermia: a new approach to local destruction of tumours. BMJ. 1989;299:362–365.
  • Satoh T, Stauffer PR, Fike JR. Thermal distribution studies of helical-coil microwave antennas for interstitial hyperthermia. Int J Radiat Oncol Biol Phys. 1988;15:1209–1218.
  • Bertram JM, Yang D, Converse MC, et al. A review of coaxial-based interstitial antennas for hepatic microwave ablation. Crit Rev Biomed Eng. 2006;34:187–213.
  • O’Rourke AP, Haemmerich D, Prakash P, et al. Current status of liver tumor ablation devices. Expert Rev Med Devices. 2007;4:523–537.
  • Astrahan MA, Norman A. A localized current field hyperthermia system for use with 192-iridium interstitial implants. Med Phys. 1982;9:419–424.
  • Visser AG, Deurloo IKK, Levendag PC, et al. An interstitial hyperthermia system at 27 MHz. Int J Hyperthermia. 1989;5:265–276.
  • Kaatee R, Crezee H, Kanis BP, et al. Spatial temperature control with a 27 MHz current source interstitial hyperthermia system. Int J Radiat Oncol Biol Phys. 1997;37:189–197.
  • van der Koijk JF, Lagendijk JJW, Crezee J, et al. The influence of vasculature on temperature distributions in MECS interstitial hyperthermia: importance of longitudinal control. Int J Hyperthermia. 1997;13:365–385.
  • Diederich CJ. Ultrasound applicators with integrated catheter-cooling for interstitial hyperthermia: theory and preliminary experiments. Int J Hyperthermia. 1996;12:279–297. Discussion 299–300.
  • Emami B. Interstitial thermoradiotherapy in the treatment of malignant tumors. In: Urano M, Douple E, editors. Interstitial hyperthermia: physics, biology and clinical aspects. Vol. 3. Utrecht (The Netherlands): VSP; 1992. p. 199–220.
  • Pyrexar Medical Inc. 2019. “BSD-500 Features”. Available from: http://www.pyrexar.com/hyperthermia/bsd-500
  • Nau WH, Diederich CJ, Stauffer PR. Directional power deposition from direct-coupled and catheter-cooled interstitial ultrasound applicators. Int J Hyperthermia. 2000;16:129–144.
  • Chopra R, Burtnyk M, N’djin WA, et al. M, MRI-controlled transurethral ultrasound therapy for localised prostate cancer. Int J Hyperthermia. 2010;26:804–821.
  • Bihrle R, Foster RS, Sanghvi NT, et al. High-intensity focused ultrasound in the treatment of prostatic tissue. Urology. 1994;43:21–26.
  • Gelet A, Chapelon JY, Margonari J, et al. High-intensity focused ultrasound experimentation on human benign prostatic hypertrophy. Eur Urol. 1993;23:44–47.
  • Hutchinson EB, Hynynen K. Intracavitary ultrasound phased arrays for prostate thermal therapies: MRI compatibility and in vivo testing. Med Phys. 1998;25:2392–2399.
  • Ahmed M, Brace CL, Lee FT, Jr, et al. Principles of and advances in percutaneous ablation. Radiology. 2011;258:351–369.
  • Hoffmann R, Rempp H, Erhard L, et al. Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver. Radiology. 2013;268:89–97.
  • Sun Y, Cheng Z, Dong L, et al. Comparison of temperature curve and ablation zone between 915- and 2450-MHz cooled-shaft microwave antenna: results in ex vivo porcine livers. Eur J Radiol. 2012;81:553–557.
  • Sawicki JF, Shea JD, Behdad N, et al. The impact of frequency on the performance of microwave ablation. Int J Hyperthermia. 2017;33:61–68.
  • Cavagnaro M, Amabile C, Bernardi P, et al. A minimally invasive antenna for microwave ablation therapies: design, performances, and experimental assessment. IEEE Trans Biomed Eng. 2011;58:949–959.
  • Al-Hakim RA, Abtin FG, Genshaft SJ, et al. Defining new metrics in microwave ablation of pulmonary tumors: ablation work and ablation resistance score. J Vasc Interv Radiol. 2016;27:1380–1386.
  • Crezee J, Lagendijk JJ. Temperature uniformity during hyperthermia: the impact of large vessels. Phys Med Biol. 1992;37:1321–1337.
  • Bredlau AL, McCrackin MA, Motamarry A, Helke K, et al. Thermal therapy approaches for treatment of brain tumors in animals and humans. Crit Rev Biomed Eng. 2016;44:443–457.
  • Carpentier A, McNichols RJ, Stafford RJ, et al. Laser thermal therapy: real-time MRI-guided and computer-controlled procedures for metastatic brain tumors. Lasers Surg Med. 2011;43:943–950.
  • Goffinet DR, Prionas SD, Kapp DS, et al. Interstitial 192Ir flexible catheter radiofrequency hyperthermia treatments of head and neck and recurrent pelvic carcinomas. Int J Radiat Oncol Biol Phys. 1990;18:199–210.
  • Prionas SD, Kapp DS, Goffinet DR, et al. Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1994;28:151–162.
  • Gillams A, Goldberg N, Ahmed M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013. Eur Radiol. 2015;25:3438–3454. 2015
  • Weiss J, Winkelmann MT, Gohla G, et al. MR-guided microwave ablation in hepatic malignancies: clinical experiences from 50 procedures. Int J Hyperthermia. 2020;37:349–355.
  • Alattar AA, Bartek J, Chian VL, et al. Stereotactic laser ablation as treatment of brain metastases recurring after stereotactic radiosurgery: a systematic literature review. World Neurosurgery. 2019;128:134–142.
  • Fucused Ultrasound Foundation. Available from: https://www.fusfoundation.org/the-technology/state-of-the-technology.
  • Peek MCL, Ahmed M, Napoli A, et al. Minimally invasive ablative techniques in the treatment of breast cancer: a systematic review and meta-analysis. Int J Hyperthermia. 2017;33:191–202.
  • Insightec. Available from: https://www.insightec.com
  • Hijnen N, Langereis S, Grull H. Magnetic resonance guided high-intensity focused ultrasound for image-guided temperature-induced drug delivery. Adv Drug Deliv Rev. 2014;72:65–81.
  • Salgaonkar VA, Prakash P, Rieke V, et al. Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array. Med Phys. 2014;41:033301.
  • Ozhinsky E, Salgaonkar VA, Diederich CJ, et al. MR thermometry-guided ultrasound hyperthermia of user-defined regions using the ExAblate prostate ablation array. J Ther Ultrasound. 2018;6:7.
  • Partanen A, Yarmolenko PS, Viitala A, et al. Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery. Int J Hyperthermia. 2012;28:320–336.
  • Hijnen NM, Heijman E, Kohler MO, et al. Tumour hyperthermia and ablation in rats using a clinical MR-HIFU system equipped with a dedicated small animal set-up. Int J Hyperthermia. 2012;28:141–155.
  • Lam MK, Oerlemans C, Froeling M, et al. DCE-MRI and IVIM-MRI of rabbit Vx2 tumors treated with MR-HIFU-induced mild hyperthermia. J Ther Ultrasound. 2016;4:9.
  • Farr N, Wang YN, D’Andrea S, et al. Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancer. Int J Hyperthermia. 2018;34:284–291.
  • Hijnen N, Kneepkens E, de Smet M, et al. Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound. Proc Natl Acad Sci U S A. 2017;114:E4802–E4811.
  • Bing CC, Patel P, Staruch RM, et al. Longer heating duration increases localized doxorubicin deposition and therapeutic index in Vx2 tumors using MR-HIFU mild hyperthermia and thermosensitive liposomal doxorubicin. Int J Hyperthermia. 2019;36:196–203.
  • Chu W, Staruch RM, Pichardo S, et al. Magnetic resonance-guided high-intensity focused ultrasound hyperthermia for recurrent rectal cancer: MR thermometry evaluation and preclinical validation. Int J Radiat Oncol Biol Phys. 2016;95:1259–1267.
  • Partanen A, Tillander M, Yarmolenko PS, et al. Reduction of peak acoustic pressure and shaping of heated region by use of multifoci sonications in MR-guided high-intensity focused ultrasound mediated mild hyperthermia. Med Phys. 2013;40:013301.
  • Yarmolenko PS, Eranki A, Partanen A, et al. Technical aspects of osteoid osteoma ablation in children using MR-guided high intensity focussed ultrasound. Int J Hyperthermia. 2018;34:49–58.
  • Alkins RD, Mainprize TG. High-intensity focused ultrasound ablation therapy of gliomas. Prog Neurol Surg. 2018;32:39–47.
  • Izadifar Z, Izadifar Z, Chapman D, et al. An introduction to high intensity focused ultrasound: systematic review on principles, devices, and clinical applications. J Clin Med. 2020;9:460.
  • Jiang CL, Davalos RV, Bischof JC. A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans Biomed Eng. 2015;62:4–20.
  • Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33:223–231.
  • Dunki-Jacobs EM, Philips P, Martin Ii RCG. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model. Br J Surg. 2014;101:1113–1121.
  • van Gemert MJC, Wagstaff PGK, de Bruin DM, et al. Irreversible electroporation: just another form of thermal therapy? Prostate. 2015;75:332–335.
  • van den Bos W, Scheffer HJ, Vogel JA, et al. Thermal energy during irreversible electroporation and the influence of different ablation parameters. J Vasc Interv Radiol. 2016;27:433–443.
  • Faroja M, Ahmed M, Appelbaum L, et al. Irreversible electroporation ablation: is all the damage nonthermal? Radiology. 2013;266:462–470.
  • Wagstaff PG, de Bruin DM, van den Bos W, et al. Irreversible electroporation of the porcine kidney: temperature development and distribution. Urol Oncol. 2015;33:168.e1–7.
  • Agnass P, Van Veldhuisen E, Van Gemert MJ, et al. Mathematical modeling of the thermal effects of irreversible electroporation for in vitro, in vivo and clinical use: a systematic review. Int J Hyperthermia. 2020:37(1):486–505.
  • Agnass P, van Veldhuisen E, Vogel JA, et al. Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series. J Clin Transl Res. 2020;5:4.
  • Garcia PA, Davalos RV, Miklavcic D. A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue. Plos One. 2014;9:e103083.
  • Byron CR, DeWitt MR, Latouche EL, et al. Treatment of infiltrative superficial tumors in awake standing horses using novel high-frequency pulsed electrical fields. Front Vet Sci. 2019;6:265.
  • Martin RC, 2nd, Durham AN, Besselink MG, et al. Irreversible electroporation in locally advanced pancreatic cancer: a call for standardization of energy delivery. J Surg Oncol. 2016;114:865–871.
  • Brezovich IA, Atkinson WJ, Mb L. Local hyperthermia with interstitial techniques. Cancer Res. 1984;44:4752–4756.
  • Brezovich IA, Lilly MB, Meredith RF, et al. Hyperthermia of pet animal tumours with self-regulating ferromagnetic thermoseeds. Int J Hyperthermia. 1990;6:117–130.
  • van Wieringen N, van Dijk JD, van Veldhuizen J, et al. The effect of catheters and coatings on the performance of palladium-nickel thermoseeds: evaluation and design of implantation techniques. Int J Hyperthermia. 1997;13:187–204.
  • Kandala SK, Liapi E, Whitcomb LL, et al. Temperature-controlled power modulation compensates for heterogeneous nanoparticle distributions: a computational optimization analysis for magnetic hyperthermia. Int J Hyperthermia. 2019;36:115–129.
  • Mack CF, Stea B, Kittelson JM, et al. Interstitial thermoradiotherapy with ferromagnetic implants for locally advanced and recurrent neoplasms. Int J Radiat Oncol Biol Phys. 1993;27:109–115.
  • Stauffer PR, van Rhoon GC. Overview of bladder heating technology: matching capabilities with clinical requirements. Int J Hyperthermia. 2016;32:407–416.
  • Colombo R, Lev A, Da Pozzo LF, et al. A new approach using local combined microwave hyperthermia and chemotherapy in superficial transitional bladder-carcinoma treatment. J Urol. 1995;153:959–963.
  • Rath-Wolfson L, Moskovitz B, Dekel Y, et al. Combined intravesical hyperthermia and mitomycin chemotherapy: a preliminary in vivo study. Int J Exp Pathol. 2003;84:145–152.
  • Schooneveldt G, Bakker A, Balidemaj E, et al. Thermal dosimetry for bladder hyperthermia treatment. An overview. Int J Hyperthermia. 2016;32:417–433.
  • Van Rhoon GC. External electromagnetic methods and devices. In: Moros EG, Hendee WR, editors. Physics of thermal therapy: fundamentals and clinical applications. Boca Raton (FL): CRC Press, Taylor & Francis Group; 2013. p. 139–158.
  • Trefna HD, Crezee J, Schmidt M, et al. Quality assurance guidelines for superficial hyperthermia clinical trials: II. Technical requirements for heating devices. Strahlentherapie Und Onkologie. 2017;193:351–366.
  • Dressel S, Gosselin MC, Capstick MH, et al. C, Novel hyperthermia applicator system allows adaptive treatment planning: preliminary clinical results in tumour-bearing animals. Vet Comp Oncol. 2018;16:202–213.
  • Van der Gaag ML, de Bruijne M, Samaras T, et al. Development of a guideline for the water bolus temperature in superficial hyperthermia. Int J Hyperthermia. 2006;22:637–656.
  • Arunachalam K, Maccarini PF, Craciunescu OI, et al. Thermal characteristics of thermobrachytherapy surface applicators for treating chest wall recurrence. Phys Med Biol. 2010;55:1949–1969.
  • Kok HP, Groen J, Bakker A, et al. Modelling curved contact flexible microstrip applicators for patient-specific superficial hyperthermia treatment planning. Cancers (Basel). 2020;12:656.
  • Lindholm CE, Kjellen E, Nilsson P, et al. Prognostic factors for tumour response and skin damage to combined radiotherapy and hyperthermia in superficial recurrent breast carcinomas. Int J Hyperthermia. 1995;11:337–355.
  • Stauffer PR, Maccarini P, Arunachalam K, et al. Conformal microwave array (CMA) applicators for hyperthermia of diffuse chest wall recurrence. Int J Hyperthermia. 2010;26:686–698.
  • Lee WM, Gelvich EA, van der Baan P, et al. Assessment of the performance characteristics of a prototype 12-element capacitive contact flexible microstrip applicator (CFMA-12) for superficial hyperthermia. Int J Hyperthermia. 2004;20:607–624.
  • Rietveld PJ, van Putten WL, Van der Zee J, et al. Comparison of the clinical effectiveness of the 433 MHz Lucite cone applicator with that of a conventional waveguide applicator in applications of superficial hyperthermia. Int J Radiat Oncol Biol Phys. 1999;43:681–687.
  • van Rhoon GC, Rietveld PJ, van der Zee J. A 433 MHz Lucite cone waveguide applicator for superficial hyperthermia. Int J Hyperthermia. 1998;14:13–27.
  • Kosterev VV, Kramer-Ageev EA, Mazokhin VN, et al. Development of a novel method to enhance the therapeutic effect on tumours by simultaneous action of radiation and heating. Int J Hyperthermia. 2015;31:443–452.
  • Maccarini PF, Arunachalam K, Juang T, et al. Shaping and resizing of multifed slot radiators used in conformal microwave antenna arrays for hyperthermia treatment of large superficial diseases. Proceedings of the 2009 International Conference on Electromagnetics in Advanced Applications; Sep 14–18; Torino, Italy. 2009.
  • Johnson JE, Neuman DG, Maccarini PF, et al. Evaluation of a dual-arm Archimedean spiral array for microwave hyperthermia. Int J Hyperthermia. 2006;22:475–490.
  • Lee ER, Wilsey TR, Tarczy-Hornoch P, et al. Body conformable 915 MHz microstrip array applicators for large surface area hyperthermia. IEEE Trans Biomed Eng. 1992;39:470–483.
  • Gelvich EA, Mazokhin VN. Contact flexible microstrip applicators (CFMA) in a range from microwaves up to short waves. IEEE Trans Biomed Eng. 2002;49:1015–1023.
  • Lamaitre G, Van Dijk JDP, Gelvich EA, et al. SAR characteristics of three types of Contact Flexible Microstrip Applicators for superficial hyperthermia. Int J Hyperthermia. 1996;12:255–269.
  • Kok HP, Correia D, De Greef M, et al. SAR deposition by curved CFMA-434 applicators for superficial hyperthermia: Measurements and simulations. Int.J.Hyperthermia. 2010;26:171–184.
  • Gelvich EA, Mazokhin VN. Resonance effects in applicator water boluses and their influence on SAR distribution patterns. Int J Hyperthermia. 2000;16:113–128.
  • Gelvich EA, Klimanov VA, Kramer-Ageev EA, et al. Computational evaluation of changes in ionizing radiation dose distribution in tissues caused by EM applicators when external radiation and hyperthermia act simultaneously. Int.J.Hyperthermia. 2006;22:343–352.
  • Overgaard J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int J Radiat Oncol Biol Phys. 1980;6:1507–1517.
  • Wust P, Ghadjar P, Nadobny J, et al. Physical analysis of temperature-dependent effects of amplitude-modulated electromagnetic hyperthermia. Int J Hyperthermia. 2019;36:1246–1254.
  • Curley SA, Palalon F, Lu X, et al. Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells. Cancer. 2014;120:3418–3425.
  • Curley SA, Palalon F, Sanders KE, et al. The effects of non-invasive radiofrequency treatment and hyperthermia on malignant and nonmalignant cells. Int J Environ Res Public Health. 2014;11:9142–9153.
  • Ware MJ, Tinger S, Colbert KL, et al. Radiofrequency treatment alters cancer cell phenotype. Sci Rep. 2015;5:12083.
  • Van Wieringen N, Wiersma J, Zum Vörde Sive Vörding PJ, et al. Characteristics and performance evaluation of the capacitive Contact Flexible Microstrip Applicator operating at 70 MHz for external hyperthermia. Int J Hyperthermia. 2009;25:542–553.
  • Wu L, McGough RJ, Arabe OA, et al. An RF phased array applicator designed for hyperthermia breast cancer treatments. Phys Med Biol. 2006;51:1–20.
  • Paulides MM, Bakker JF, Neufeld E, et al. Winner of the “New Investigator Award” at the European Society of Hyperthermia Oncology Meeting 2007. The HYPERcollar: a novel applicator for hyperthermia in the head and neck. Int J Hyperthermia. 2007;23:567–576.
  • Paulides MM, Bakker JF, Hofstetter LW, et al. Laboratory prototype for experimental validation of MR-guided radiofrequency head and neck hyperthermia. Phys Med Biol. 2014;59:2139–2154.
  • Corry PM, Barlogie B, Tilchen EJ, et al. Ultrasound-induced hyperthermia for the treatment of human superficial tumors. Int J Radiat Oncol Biol Phys. 1982;8:1225–1229.
  • Underwood HR, Burdette EC, Ocheltree KB, et al. A multi-element ultrasonic hyperthermia applicator with independent element control. Int J Hyperthermia. 1987;3:257–267.
  • Moros EG, Fan X, Straube WL. Experimental assessment of power and temperature penetration depth control with a dual frequency ultrasonic system. Med Phys. 1999;26:810–817.
  • Novak P, Moros EG, Straube WL, et al. SURLAS: a new clinical grade ultrasound system for sequential or concomitant thermoradiotherapy of superficial tumors: applicator description. Med Phys. 2005;32:230–240.
  • Van Leeuwen CM, Oei AL, Chin K, et al. A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer. Radiat Oncol. 2017;12:75.
  • van Leeuwen CM, Crezee J, Oei AL, et al. The effect of time interval between radiotherapy and hyperthermia on planned equivalent radiation dose. Int J Hyperthermia. 2018;34:901–909.
  • Kato H, Hyodo K, Akasaka N, et al. Optimization of bolus for capacitive type heating. Jpn J Hyperthermic Oncol. 1997;13:10–17.
  • Paulsen KD, Geimer S, Tang J, et al. Optimization of pelvic heating rate distributions with electromagnetic phased arrays. Int J Hyperthermia. 1999;15:157–186.
  • Wust P, Seebass M, Nadobny J, et al. Simulation studies promote technological development of radiofrequency phased array hyperthermia. Int.J.Hyperthermia. 1996;12:477–494.
  • Kok HP, De Greef M, Borsboom PP, et al. Improved power steering with double and triple ring waveguide systems: the impact of the operating frequency. Int J Hyperthermia. 2011;27:224–239.
  • Turner PF, Tumeh A, Schaefermeyer T, et al. approach for deep local and regional hyperthermia: physics and technology. Strahlenther Onkol. 1989;165:738–741.
  • Zweije R, Kok HP, Bakker A, et al. Technical and clinical evaluation of the ALBA-4D 70MHz loco-regional hyperthermia system. Proceedings of the 48th European Microwave Conference. 2018. p. 328–331.
  • Gellermann J, Wust P, Stalling D, et al. Clinical evaluation and verification of the hyperthermia treatment planning system hyperplan. Int J Radiat Oncol Biol Phys. 2000;47:1145–1156.
  • Sreenivasa G, Gellermann J, Rau B, et al. Clinical use of the hyperthermia treatment planning system HyperPlan to predict effectiveness and toxicity. Int J Radiat Oncol Biol Phys. 2003;55:407–419.
  • Van Haaren PMA, Kok HP, Van den Berg CAT, et al. On verification of hyperthermia treatment planning for cervical carcinoma patients. Int J Hyperthermia. 2007;23:303–314.
  • Van Haaren P, Kok P, Van Stam G, et al. SAR measurements and FDTD calculations in inhomogeneous phantom models. Proceedings of the 9th International Congress on Hyperthermic Oncology; 2004; St.Louis, MA. Abstracts. 2004. p. 167.
  • Wust P, Beck R, Berger J, et al. Electric field distributions in a phased-array applicator with 12 channels: measurements and numerical simulations. Med Phys. 2000;27:2565–2579.
  • Wust P, Fahling H, Wlodarczyk W, et al. Antenna arrays in the SIGMA-eye applicator: interactions and transforming networks. Med Phys. 2001;28:1793–1805.
  • Weihrauch M, Wust P, Weiser M, et al. Adaptation of antenna profiles for control of MR guided hyperthermia (HT) in a hybrid MR-HT system. Med Phys. 2007;34:4717–4725.
  • Gellermann J, Hildebrandt B, Issels R, et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer. 2006;107:1373–1382.
  • Gellermann J, Wlodarczyk W, Hildebrandt B, et al. Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res. 2005;65:5872–5880.
  • Gellermann J, Wlodarczyk W, Ganter H, et al. A practical approach to thermography in a hyperthermia/magnetic resonance hybrid system: validation in a heterogeneous phantom. Int J Radiat Oncol Biol Phys. 2005;61:267–277.
  • Mulder HT, Curto S, Paulides MM, et al. Systematic quality assurance of the BSD2000-3D MR-compatible hyperthermia applicator performance using MR temperature imaging. Int J Hyperthermia. 2018;35:305–313.
  • van Dijk JDP, Schneider CJ, van Os RM, et al. Results of deep body hyperthermia with large waveguide radiators. Adv Exp Med Biol. 1990;267:315–319.
  • Crezee J, Van Haaren PMA, Westendorp H, et al. Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: a preclinical study. Int J Hyperthermia. 2009;25:581–592.
  • Ott OJ, Schmidt M, Semrau S, et al. Chemoradiotherapy with and without deep regional hyperthermia for squamous cell carcinoma of the anus. Strahlenther Onkol. 2019;195:607–614.
  • Datta NR, Pestalozzi B, Clavien PA, et al.; members of the HEATPAC Trial Group. “HEATPAC” – a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer. Radiat Oncol. 2017;12:183.
  • Gani C, Bonomo P, Zwirner K, et al. Organ preservation in rectal cancer – challenges and future strategies. Clin Transl Radiat Oncol. 2017;3:9–15.
  • Carlier C, Mathys A, De Jaeghere E, et al. Tumour tissue transport after intraperitoneal anticancer drug delivery. Int J Hyperthermia. 2017;33:534–542.
  • Klaver CEL, Musters GD, Bemelman WA, et al. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial. BMC Cancer. 2015;15:428.
  • Sugarbaker PH. Strategies to improve local control of resected pancreas adenocarcinoma. Surg Oncol. 2017;26:63–70.
  • Klaver CEL, Wisselink DD, Punt CJA, et al.; COLOPEC collaborators group. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol. 2019;4:761–770.
  • Goere D, Glehen O, Quenet F, et al.; BIG-RENAPE and PRODIGE. Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-NTC01226394). J Clin Oncol. 2018;36:3531–3531.
  • Ceelen W. HIPEC with oxaliplatin for colorectal peritoneal metastasis: the end of the road? Eur J Surg Oncol. 2019;45:400–402.
  • Rau B, Brandl A, Piso P, et al.; Peritoneum Surface Oncology Group and members of the StuDoQ|Peritoneum Registry of the German Society for General and Visceral Surgery (DGAV). Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer. 2019;23:11–22.
  • Bull JM, Scott GL, Strebel FR, et al. Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol. Int J Hyperthermia. 2008;24:649–662.
  • Hildebrandt B, Hegewisch-Becker S, Kerner T, et al. Current status of radiant whole-body hyperthermia at temperatures > 41.5 degrees C and practical guidelines for the treatment of adults. The German ‘Interdisciplinary Working Group on Hyperthermia. Int J Hyperthermia. 2005;21:169–183.
  • Janssen CW, Lowry CA, Mehl MR, et al. Whole-body hyperthermia for the treatment of major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2016;73:789–795.
  • Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res. 1984;44:4721s–4730s.
  • Franckena M, Fatehi D, de Bruijne M, et al. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer. 2009;45:1969–1978.
  • Linthorst M, Baaijens M, Wiggenraad R, et al. Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients. Radiother Oncol. 2015;117:217–222.
  • Bakker A, Kolff MW, Holman R, et al. Thermal skin damage during reirradiation and hyperthermia is time-temperature dependent. Int J Radiat Oncol Biol Phys. 2017;98:392–399.
  • Saccomandi P, Schena E, Silvestri S. Techniques for temperature monitoring during laser-induced thermotherapy: An overview. Int J Hyperthermia. 2013;29:609–619.
  • Lewis MA, Staruch RM, Chopra R. Thermometry and ablation monitoring with ultrasound. Int J Hyperthermia. 2015;31:163–181.
  • De Leeuw AAC, Crezee J, Lagendijk JJW. Temperature and SAR measurements in deep-body hyperthermia with thermocouple thermometry. Int J Hyperthermia. 1993;9:685–697.
  • Hynynen K, Edwards DK. Temperature measurements during ultrasound hyperthermia. Med Phys. 1989;16:618–626.
  • Morris H, Rivens I, Shaw A, et al. Investigation of the viscous heating artefact arising from the use of thermocouples in a focused ultrasound field. Phys Med Biol. 2008;53:4759–4776.
  • Winter L, Oberacker E, Paul K, et al. Magnetic resonance thermometry: Methodology, pitfalls and practical solutions. Int J Hyperthermia. 2016;32:63–75.
  • Fani F, Schena E, Saccomandi P, et al. CT-based thermometry: an overview. Int J Hyperthermia. 2014;30:219–227.
  • Miyakawa M, Bolomey JC. Non-invasive thermometry of the human body. Boca Raton (FL): CRC Press; 1995.
  • Bharat S, Techavipoo U, Kiss MZ, et al. Monitoring stiffness changes in lesions after radiofrequency ablation at different temperatures and durations of ablation. Ultrasound Med Biol. 2005;31:415–422.
  • Ishihara Y, Calderon A, Watanabe H, et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med. 1995;34:814–823.
  • Kothapalli SV, Altman MB, Zhu L, et al. Evaluation and selection of anatomic sites for magnetic resonance imaging-guided mild hyperthermia therapy: a healthy volunteer study. Int J Hyperthermia. 2018;34:1381–1389.
  • Li Z, Vogel M, Maccarini PF, et al. Improved hyperthermia treatment control using SAR/temperature simulation and PRFS magnetic resonance thermal imaging. Int J Hyperthermia. 2011;27:86–99.
  • Salomir R, Palussière, J, Vimeux FC, et al. Local hyperthermia with MR-guided focused ultrasound: spiral trajectory of the focal point optimized for temperature uniformity in the target region. J Magn Reson Imaging. 2000;12:571–583.
  • Kim YS. Advances in MR image-guided high-intensity focused ultrasound therapy. Int J Hyperthermia. 2015;31:225–232.
  • Siedek F, Yeo SY, Heijman E, et al. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU): technical background and overview of current clinical applications (part 1). Rofo. 2019;191:522–530.
  • Siedek F, Yeo SY, Heijman E, et al. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU): overview of emerging applications (part 2). Rofo. 2019;191:531–539.
  • Cline HE, Schenck JF, Hynynen K, et al. MR-guided focused ultrasound surgery. J Comput Assist Tomogr. 1992;16:956–965.
  • Sanghvi NT, Chen WH, Carlson R, et al. Clinical validation of real-time tissue change monitoring during prostate tissue ablation with high intensity focused ultrasound. J Ther Ultrasound. 2017;5:24
  • Pichardo S, Gelet A, Curiel L, et al. New integrated imaging high intensity focused ultrasound probe for transrectal prostate cancer treatment. Ultrasound Med Biol. 2008;34:1105–1116.
  • Shahmirzadi D, Hou GY, Chen J, et al. Ex Vivo characterization of canine liver tissue viscoelasticity after high-intensity focused ultrasound ablation . Ultrasound Med Biol. 2014;40:341–350.
  • Kok HP, Wust P, Stauffer PR, et al. Current state of the art of regional hyperthermia treatment planning: a review. Radiat Oncol. 2015;10:196
  • De Greef M, Kok HP, Correia D, et al. Optimization in hyperthermia treatment planning: the impact of tissue perfusion uncertainty. Med Phys. 2010;37:4540–4550.
  • De Greef M, Kok HP, Correia D, et al. Uncertainty in hyperthermia treatment planning: the need for robust system design. Phys Med Biol. 2011;56:3233–3250.
  • van de Kamer JB, Van Wieringen N, De Leeuw AAC, et al. The significance of accurate dielectric tissue data for hyperthermia treatment planning. Int J Hyperthermia. 2001;17:123–142.
  • Edd JF, Davalos RV. Mathematical modeling of irreversible electroporation for treatment planning. Technol Cancer Res Treat. 2007;6:275–286.
  • Neal RE, Garcia PA, Robertson JL, et al. Experimental characterization and numerical modeling of tissue electrical conductivity during pulsed electric fields for irreversible electroporation treatment planning. IEEE Trans Biomed Eng. 2012;59:1076–1085.
  • Porcheron J, Talabard JN, Breton C, et al. Intraperitoneal chemohyperthermia for peritoneal carcinomatosis: original modeling, clinical tolerance and results study about 30 patients. Hepatogastroenterology. 2000;47:1411–1418.
  • Ladhari T, Szafnicki K. Modelling of some aspects of a biomedical process: application to the treatment of digestive cancer (HIPEC). 3 Biotech. 2018;8:190.
  • Stigliano RV, Shubitidze F, Petryk AA, et al. Magnetic nanoparticle hyperthermia: predictive model for temperature distribution. Proc SPIE Int Soc Opt Eng. 2013;8584:858410.
  • Berjano EJ. Theoretical modeling for radiofrequency ablation: state-of-the-art and challenges for the future. Biomed Eng Online. 2006;5:24.
  • Schumann C, Rieder C, Haase S, et al. Interactive multi-criteria planning for radiofrequency ablation. Int J Comput Assist Radiol Surg. 2015;10:879–889.
  • Reinhardt M, Brandmaier P, Seider D, et al.; ClinicIMPPACT Study Group. A prospective development study of software-guided radio-frequency ablation of primary and secondary liver tumors: clinical intervention modelling, planning and proof for ablation cancer treatment (ClinicIMPPACT). Contemp Clin Trials Commun. 2017;8:25–32.
  • Lopresto V, Pinto R, Farina L, et al. Treatment planning in microwave thermal ablation: clinical gaps and recent research advances. Int J Hyperthermia. 2016;:1–39.
  • Yero DD, Gonzalez FG, Van Troyen D, et al. Dielectric properties of ex vivo porcine liver tissue characterized at frequencies between 5 and 500 kHz when heated at different rates. IEEE Trans Biomed Eng. 2018;65:2560–2568.
  • Sebek J, Albin N, Bortel R, et al. Sensitivity of microwave ablation models to tissue biophysical properties: A first step toward probabilistic modeling and treatment planning. Med Phys. 2016;43:2649.
  • Chen D, Xia R, Chen X, et al. SonoKnife: feasibility of a line-focused ultrasound device for thermal ablation therapy. Med Phys. 2011;38:4372–4385.
  • Nikolov SI, Jensen JA. Application of different spatial sampling patterns for sparse array transducer design. Ultrasonics. 2000;37:667–671.
  • de Bruijne M, Wielheesen DH, Van der Zee J, et al. Benefits of superficial hyperthermia treatment planning: five case studies. Int J Hyperthermia. 2007;23:417–429.
  • Trujillo-Romero CJ, Paulides MM, Drizdal T, et al. Impact of silicone and metal port-a-cath implants on superficial hyperthermia treatment quality. Int J Hyperthermia. 2015;31:15–22.
  • Franckena M, Canters R, Termorshuizen F, et al. Clinical implementation of hyperthermia treatment planning guided steering: A cross over trial to assess its current contribution to treatment quality. Int J Hyperthermia. 2010;26:145–157.
  • Kok HP, Ciampa S, De Kroon-Oldenhof R, et al. Toward on-line adaptive hyperthermia treatment planning: correlation between measured and simulated specific absorption rate changes caused by phase steering in patients. Int.J.Radiat.Oncol.Biol.Phys. 2014;90:438–445.
  • Kok HP, Schooneveldt G, Bakker A, et al. Predictive value of simulated SAR and temperature for changes in measured temperature after phase-amplitude steering during locoregional hyperthermia treatments. Int J Hyperthermia. 2018;35:330–339.
  • Kok HP, Korshuize-van Straten L, Bakker A, et al. Feasibility of on-line temperature-based hyperthermia treatment planning to improve tumour temperatures during locoregional hyperthermia. Int J Hyperthermia. 2018;34:1082–1091.
  • Rijnen Z, Bakker JF, Canters RA, et al. Clinical integration of software tool VEDO for adaptive and quantitative application of phased array hyperthermia in the head and neck. Int J Hyperthermia. 2013;29:181–193.
  • Kok HP, Crezee J, Franken NAP, et al. Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distributions. Int J Radiat Oncol Biol Phys. 2014;88:739–745.
  • Crezee J, van Leeuwen CM, Oei AL, et al. Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer. Radiat Oncol. 2016;11:14
  • Kok HP, Van Dijk I, Crama KF, et al. Re-irradiation plus hyperthermia for recurrent pediatric sarcoma; a simulation study to investigate feasibility. Int J Oncol. 2019;54:209–218.
  • Crezee H, van Leeuwen CM, Oei AL, et al. Thermoradiotherapy planning: Integration in routine clinical practice. Int J Hyperthermia. 2016;32:41–49.
  • Schooneveldt G, Dobsicek Trefna H, Persson M, et al. Hyperthermia treatment planning including convective flow in cerebrospinal fluid for brain tumour hyperthermia treatment using a novel dedicated paediatric brain applicator. Cancers (Basel. 2019;11:1183.
  • Coluccia D, Fandino J, Schwyzer L, et al. First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound. J Ther Ultrasound. 2014;2:17.
  • Kok HP, Beck M, Loke DR, et al. Locoregional peritoneal hyperthermia to enhance the effectiveness of chemotherapy in patients with peritoneal carcinomatosis: a simulation study comparing different locoregional heating systems. Int J Hyperthermia. 2020;37:76–88.
  • Hoopes PJ, Wagner RJ, Duval K, et al. Treatment of canine oral melanoma with nanotechnology-based immunotherapy and radiation. Mol Pharm. 2018;15:3717–3722.
  • Chao Y, Chen G, Liang C, et al. Iron nanoparticles for low-power local magnetic hyperthermia in combination with immune checkpoint blockade for systemic antitumor therapy. Nano Lett. 2019;19:4287–4296.
  • Oei AL, Korangath P, Mulka K, et al. Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer. Int J Hyperthermia. 2019;36:47–63.
  • Duval KEA, Vernice NA, Wagner RJ, et al. Immunogenetic effects of low dose (CEM43 30) magnetic nanoparticle hyperthermia and radiation in melanoma cells. Int J Hyperthermia. 2019;36:37–46.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.